Research article · 28 Oct 2020
Conference abstractPublished 19 Oct 2017
Parenteral dosage forms differ from all other pharmaceutical dosage forms
Sanovel Pharmaceuticals, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Parenteral dosage forms differ from all other pharmaceutical dosage forms, because they are injected directly into body tissue through the primary protective systems of the human body; the skin and mucous membranes. They have many advantages like routes of administration, elimination of first pass effect and better absorption. They can be in a solution, suspension, emulsions, dry powders with freeze drying as well as microcapsules, nanoparticules or microemulsions. But there are some limitations for formulation development studies like drug stability, poor solubility, packaging, controlling the quality of these unique products, sterilization methods and evaluation of parenteral dosage forms issues. So,the main formulation development steps for new parenteral drug products And what about QbD development approach for parenteral dosage formsParenteral dosage forms represent excellent opportunities for life cycle management to the pharmaceutical companies. the future of parenteral dosage forms formulations. Sustained release drug delivery, such as depot formulations which are already available at the market, may be a good alternative.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 10 May 2016
Difference spectroscopic and reverse phase HPLC methods for the estimation of cefdinir in pharmaceutical dosage forms
Research article · 30 Jun 2015
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ONDONSETRAN USING REVERSE PHASE HPLC METHOD andITâ??S APPLICATION TO DIFFERENT PHARMACEUTICAL DOSAGE FORMS
Article · 2013
Development and Validation of difference pectrophotometric method for the estimation of Famotidine in bulk and Pharmaceutical dosage Form
Research article · 31 Jul 2017
A Validated RP-HPLC Method for the Determination of 2-Chloroadenosine As Process Related Impurity in Regadenosen Parenteral Dosage Form
More from this journal
The newest in Drug Designing: Open Access.
Research article · 19 Aug 2025
Spectroscopic, Quantum Chemical, Molecular Docking Studies on Cellulose Acetate: Polyvinylidene Fluoride Blend Polymer Membrane for Wound Healing
Research article · 18 Apr 2025
Molecular Docking Studies on Polyphenols of Moringa oleifera for its Enhanced Production of Heamoglobin and Impact of its Extracts on Drosophila melanogaster
Opinion · 4 Mar 2025
Structure-Based Drug Design: Advances in Targeting Oncogenic Kinases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gulay Yelken Demırel”

